Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Observational Study Evaluating the Body Weight Progress During the Treatment With Insulin Detemir (Levemir) in Type 2 Patients, Previously Treated With Other Basal Insulins.

Trial Profile

Observational Study Evaluating the Body Weight Progress During the Treatment With Insulin Detemir (Levemir) in Type 2 Patients, Previously Treated With Other Basal Insulins.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Nov 2016

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 13 Jan 2010 Planned number of patients changed from 200 to 206 as reported by ClinicalTrials.gov.
    • 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top